Home/Filings/4/0001209191-22-043769
4//SEC Filing

Kidron Miriam 4

Accession 0001209191-22-043769

CIK 0001176309other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 8:00 PM ET

Size

6.6 KB

Accession

0001209191-22-043769

Insider Transaction Report

Form 4
Period: 2022-07-28
Kidron Miriam
DirectorChief Scientific Officer
Transactions
  • Award

    Common Stock

    2022-07-28+34,000217,666 total
  • Award

    Common Stock

    2022-07-28+84,000301,666 total
Footnotes (2)
  • [F1]Represents Common Stock granted by the Issuer that vested on August 1, 2022.
  • [F2]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 28,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001409232

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 8:00 PM ET
Size
6.6 KB